Postreperfusion Syndrome
📧 Sign up to get email alerts when something new happens for Postreperfusion Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation [Phase 2]
Phase 2 clinical trial evaluating ascorbic acid to prevent postreperfusion syndrome in liver transplantation.
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Comparison of PRS According to Inhalation Agent During LDLT [Phase 4]
A Phase 4 trial comparing postreperfusion syndrome during living donor liver transplantation using different inhalation anesthetic agents ha…
-
CLINICAL_TRIALS trial_result · 2010-05-03Clinical Trial Update: Effect of Nafamostat on Postreperfusion Syndrome (PRS) [Phase 4]
Phase 4 clinical trial evaluated Nafamostat for effects on postreperfusion syndrome in liver transplant patients; results were posted in 201…